• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IDH2 和 TET2 突变协同调节滤泡辅助性 T 细胞与 AITL 微环境的功能相互作用。

IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.

机构信息

University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.

University Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, 94010 Créteil, France; AP-HP, Lymphoid Malignancies Unit, Henri Mondor Hospital, 94010 Créteil, France.

出版信息

Cancer Cell. 2023 Feb 13;41(2):323-339.e10. doi: 10.1016/j.ccell.2023.01.003. Epub 2023 Feb 2.

DOI:10.1016/j.ccell.2023.01.003
PMID:36736318
Abstract

Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma that originates from T follicular helper (Tfh) cells and exhibits a prominent tumor microenvironment (TME). IDH2 and TET2 mutations co-occur frequently in AITL, but their contribution to tumorigenesis is poorly understood. We developed an AITL mouse model that is driven by Idh2 and Tet2 mutations. Malignant Tfh cells display aberrant transcriptomic and epigenetic programs that impair TCR signaling. Neoplastic Tfh cells bearing combined Idh2 and Tet2 mutations show altered cross-talk with germinal center B cells that promotes B cell clonal expansion while decreasing Fas-FasL interaction and reducing B cell apoptosis. The plasma cell count and angiogenesis are also increased in the Idh2-mutated tumors, implying a major relationship between Idh2 mutation and the characteristic AITL TME. Our mouse model recapitulates several features of human IDH2-mutated AITL and provides a rationale for exploring therapeutic targeting of Tfh-TME cross-talk for AITL patients.

摘要

血管免疫母细胞性 T 细胞淋巴瘤 (AITL) 是一种外周 T 细胞淋巴瘤,起源于滤泡辅助性 T 细胞 (Tfh),并表现出明显的肿瘤微环境 (TME)。IDH2 和 TET2 突变在 AITL 中经常同时发生,但它们对肿瘤发生的贡献尚不清楚。我们开发了一种由 Idh2 和 Tet2 突变驱动的 AITL 小鼠模型。恶性 Tfh 细胞表现出异常的转录组和表观遗传程序,损害 TCR 信号。携带 IDH2 和 TET2 突变的肿瘤性 Tfh 细胞与生发中心 B 细胞的异常相互作用促进了 B 细胞克隆扩增,同时降低了 Fas-FasL 相互作用,减少了 B 细胞凋亡。Idh2 突变瘤中的浆细胞计数和血管生成也增加,这意味着 Idh2 突变与 AITL 特征性 TME 之间存在重要关系。我们的小鼠模型再现了人类 IDH2 突变型 AITL 的几个特征,并为探索针对 Tfh-TME 相互作用的治疗靶向提供了依据,以治疗 AITL 患者。

相似文献

1
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.IDH2 和 TET2 突变协同调节滤泡辅助性 T 细胞与 AITL 微环境的功能相互作用。
Cancer Cell. 2023 Feb 13;41(2):323-339.e10. doi: 10.1016/j.ccell.2023.01.003. Epub 2023 Feb 2.
2
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.血管免疫母细胞性 T 细胞淋巴瘤中 RHOA 突变的临床病理意义:一项荟萃分析:AITL 中的 RHOA 突变。
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):431-438. doi: 10.1016/j.clml.2021.03.002. Epub 2021 Mar 19.
3
Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.克隆性造血与骨髓浸润在生发中心 B 细胞型滤泡辅助性 T 细胞淋巴瘤患者中的临床意义
Mod Pathol. 2024 Jul;37(7):100519. doi: 10.1016/j.modpat.2024.100519. Epub 2024 May 21.
4
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.血管免疫母细胞性 T 细胞淋巴瘤包含多个克隆 T 细胞群体,这些细胞来源于一个共同的 TET2 突变祖细胞。
J Pathol. 2020 Mar;250(3):346-357. doi: 10.1002/path.5376. Epub 2020 Jan 16.
5
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.血管免疫母细胞性T细胞淋巴瘤:通过突变谱分析获得的新分子见解
Oncotarget. 2017 Mar 14;8(11):17763-17770. doi: 10.18632/oncotarget.14846.
6
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.克隆性造血中两种不同淋巴样增殖的平行进化。
Histopathology. 2022 Apr;80(5):847-858. doi: 10.1111/his.14619. Epub 2022 Mar 1.
7
TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.血管免疫母细胞性T细胞淋巴瘤患者B细胞中的TET2突变
J Pathol. 2017 Jun;242(2):129-133. doi: 10.1002/path.4898. Epub 2017 May 3.
8
Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.血管免疫母细胞性T细胞淋巴瘤:不仅仅是一种T滤泡辅助细胞疾病。
J Pathol. 2017 Aug;242(4):387-390. doi: 10.1002/path.4920. Epub 2017 Jun 29.
9
BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.在血管免疫母细胞性T细胞淋巴瘤中,BCL6基因座发生高甲基化。
Int J Hematol. 2017 Apr;105(4):465-469. doi: 10.1007/s12185-016-2159-z. Epub 2016 Dec 5.
10
Clonal germinal center B cells function as a niche for T-cell lymphoma.克隆性生发中心 B 细胞作为 T 细胞淋巴瘤的龛细胞发挥作用。
Blood. 2022 Nov 3;140(18):1937-1950. doi: 10.1182/blood.2022015451.

引用本文的文献

1
A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiation.一种统一的网络系统方法揭示了T滤泡辅助细胞分化背后的一个核心新程序。
bioRxiv. 2025 Aug 24:2025.08.19.670906. doi: 10.1101/2025.08.19.670906.
2
Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.循环肿瘤DNA是血管免疫母细胞性T细胞淋巴瘤反应的生物标志物。
Int J Mol Sci. 2025 Jul 13;26(14):6719. doi: 10.3390/ijms26146719.
3
Angioimmunoblastic T-cell lymphoma: a concise overview encompassing the pathogenetic, pathological, clinical, therapeutical characteristics, and recent advances.
血管免疫母细胞性T细胞淋巴瘤:涵盖发病机制、病理、临床、治疗特征及最新进展的简要概述
Clin Exp Med. 2025 Jun 25;25(1):218. doi: 10.1007/s10238-025-01754-4.
4
Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas.外周T细胞淋巴瘤基因改变的生物学及临床相关性
JMA J. 2025 Apr 28;8(2):345-353. doi: 10.31662/jmaj.2024-0405. Epub 2025 Mar 7.
5
Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model.阿扎胞苷在患者来源的异种移植滤泡辅助性T细胞淋巴瘤模型中诱导p53介导的细胞凋亡
Leukemia. 2025 May 20. doi: 10.1038/s41375-025-02628-0.
6
Molecular Biology and Functions of T Follicular Helper Cells in Cancer and Immunotherapy.癌症与免疫治疗中滤泡辅助性T细胞的分子生物学及功能
Immune Netw. 2025 Feb 11;25(2):e7. doi: 10.4110/in.2025.25.e7. eCollection 2025 Apr.
7
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.TP53和CDKN2A改变定义了淋巴结T滤泡辅助细胞淋巴瘤患者的一个预后不良亚组。
Leukemia. 2025 May 2. doi: 10.1038/s41375-025-02631-5.
8
Management of T-cell malignancies: Bench-to-bedside targeting of epigenetic biology.T细胞恶性肿瘤的管理:从 bench 到床边的表观遗传生物学靶向治疗
CA Cancer J Clin. 2025 Jul-Aug;75(4):282-307. doi: 10.3322/caac.70001. Epub 2025 Apr 15.
9
Malignant solid tumor-related spontaneous intracerebral hemorrhage: a propensity score matching study.恶性实体瘤相关的自发性脑出血:一项倾向评分匹配研究。
PeerJ. 2024 Dec 23;12:e18737. doi: 10.7717/peerj.18737. eCollection 2024.
10
Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets.外周T细胞淋巴瘤的进展:发病机制、基因图谱及新兴治疗靶点
Histopathology. 2025 Jan;86(1):119-133. doi: 10.1111/his.15376.